MedTrace Logo

Topical Ethanol Extract (Piper Crocatum) for Anogenital Warts

NCT05622916 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-11-21

No results posted yet for this study

Summary

This clinical trial aims to assess the efficacy of topical Piper crocatum in treating Anogenital warts. It aims to answer

* the clinical efficacy of treating anogenital warts
* the expression of Foxp3+ regulatory T (Treg), TGF/Tumor Growth Factor -β1, and IFN/interferon -γ of anogenital wart lesion Participants will be allocated into two topical treatments, intervention and active comparator Trichloroacetic Acid (TCA) 90%. The researchers assume that intervention is superior compared to TCA 90%

Conditions

  • Anogenital Wart

Interventions

DRUG

Topical Ethanol Extract (Piper crocatum)

Topical ethanol extract of red betel leaves (Piper crocatum) 30% with the details of formulation on detailed description section

DRUG

Trichloroacetic Acid Topical

Trichloroacetic acid topical 90%

Sponsors & Collaborators

  • Hasanuddin University

    lead OTHER

Principal Investigators

  • Idrianti Idrus, MD · Hasanuddin University

  • Wresti Indriatmi, MD. Ph.D · Indonesia University

  • Fransiscus Suyatna, MD. Ph.D · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2023-02-28
Completion
2023-04-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622916 on ClinicalTrials.gov